Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Acer Therapeutics Inc./ EFFECT

SEC Filing · EFFECT

Acer Therapeutics Inc.

SEC Filing

Filed Nov 24, 2023Accepted Nov 26, 2023, 7:15 PM ESTCIK 1069308Accession 9999999995-23-003428
View company →Permanent SEC source ↗
Share

Company context

Historical securities (2)
ACERWNASDAQ · WARRANT · Historical · closed Apr 6, 2018OPXAWNASDAQ · WARRANT · Historical · closed Jan 15, 2025

Recent company filings

  1. 15-12G filingNov 30, 2023
  2. EFFECT filingNov 24, 2023
  3. 4 filingNov 20, 2023
  4. 4 filingNov 20, 2023
  5. 4 filingNov 20, 2023

As-filed source

Primary evidence
As filedOpen full document ↗